Yosemite Fund II

vc$200MCo-investsLeads rounds

◆ Fund Size

$200M

◆ Check Size

$1.0M→$10.0M

◆ Location

United States

◆ Activity

Statusactively investing

◆ Links

Website ↗

◆ Investment Thesis

Oncology-focused venture firm building biotech companies from scratch out of early academic research using a mix of philanthropy and outside investment capital. Uses AI for drug discovery and clinical trial design.

◆ About Yosemite

Yosemite is a venture capital firm focused on investing in innovative solutions that address cancer, with a mission to transform the landscape of cancer treatment and care.

◆ Sectors

BiotechDrug DiscoveryAI InfrastructureDiagnostics

◆ Stages

pre-seedseedseries-aseries-b

◆ Geography Focus

United States

◆ Team

Name	Title	Role	Links
Anna Darbyshire	Chief Operating Officer	Senior	in 𝕏
Carrie Kibler	General Counsel	Senior	in
Dan McHugh	Head of Investment Team	Senior	in
Koki Kikukawa	Founder and Chief Executive Officer	Founder	in 𝕏
Reed Jobs	Founder and President	Founder	in

◆ Notable Investments

Turquoise HealthTune TherapeuticsShinobi TherapeuticsTigaTxDaymark HealthMaia OncologyAzalea TherapeuticsQuarryChai Discovery

◆ Traits

Leads rounds

Co-invests

◆ FAQ

What does Yosemite Fund II invest in?

Yosemite Fund II invests in Biotech, Drug Discovery, AI Infrastructure and Diagnostics at the pre-seed, seed, series-a and series-b stages.

Which geographies does Yosemite Fund II focus on?

Yosemite Fund II focuses on United States, and is headquartered in United States.

What is Yosemite Fund II's typical check size?

Yosemite Fund II typically writes checks of $1M to $10M.